Application 211810

Type
NDA
Sponsor
DAIICHI SANKYO INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TURALIOPEXIDARTINIB HYDROCHLORIDECAPSULE;ORALEQ 200MG BASEYesYes
002TURALIOPEXIDARTINIB HYDROCHLORIDECAPSULE;ORALEQ 125MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65597-402TuraliopexidartinibDaiichi Sankyo Inc.NDACurrent
65597-402TuraliopexidartinibDaiichi Sankyo Inc.NDACurrent
65597-402TuraliopexidartinibDaiichi Sankyo, Inc.NDACurrent
65597-402TuraliopexidartinibDaiichi Sankyo Inc.NDACurrent
65597-402TuraliopexidartinibDaiichi Sankyo, Inc.NDACurrent
65597-402TuraliopexidartinibDaiichi Sankyo Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83226SUPPL 2025-08-29
80834SUPPL 2025-01-13
80816SUPPL 2025-01-06
80814SUPPL 2025-01-03
76626SUPPL 2023-11-17
76601SUPPL 2023-11-17
76275ORIG 2023-11-03
72392SUPPL2022-10-17
72391SUPPL2022-10-17
72348SUPPL2022-10-17
72268SUPPL2022-10-07
71573SUPPL2022-07-15
71572SUPPL2022-07-15
71560SUPPL2022-07-15
69068SUPPL2021-10-22
69059SUPPL2021-10-21
69058SUPPL2021-10-21
65656SUPPL2020-12-21
65644SUPPL2020-12-21
64199SUPPL2020-08-05
62656SUPPL2020-04-23
62655SUPPL2020-04-23
62600SUPPL2020-04-17
60996SUPPL2019-11-20
60995SUPPL2019-11-20
59742ORIG2019-08-19
59574ORIG2019-08-05
59569ORIG2019-08-02
59568ORIG2019-08-02